Harikumar et al.[12] demonstrated that sesamin down-regulates constitutive and inducible NF-κB activation and expression in human chronic myeloid leukemia cell lines. This evidence concerns the gene NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive.